A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

With the Chromatin Immunoprecipitation Testing market projected to double by 2035, the message for manufacturers is clear: ...

Emma's brain tumour has stopped growing since she gained access to a type of immunotherapy identified by molecular testing.

A new method to detect ribonucleic acid (RNA) without needing any complex lab procedures or heating equipment has been ...

In her role, Bumpus will serve as a part-time strategic advisor to Charles River, a spokesperson for the company told Fierce ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

That gives the test utility in monitoring drinking water for two of the most toxic “forever chemicals,” perfluorooctanoic ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...

Beta-thalassemia is a genetic disorder that significantly burdens healthcare systems globally. This inherited blood disorder, categorized into beta-thalassemia and alpha-thalassemia, results in ...